Picture of Senzime AB (publ) logo

SEZI — Senzime AB (publ) News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Sweden's Senzime Q3 sales rise on strong sensor demand

Sweden's Senzime Q3 sales rise on strong sensor demand


Overview

  • Sweden medical device maker's Q3 net sales rose 14% yr/yr on strong sensor demand

  • Gross margin improved to 74% from 61% as recurring sensor sales grew

  • EBITDA loss narrowed to SEK 8 mln from SEK 19 mln as costs declined


Outlook

  • Company maintains target of achieving positive cash flow in Q4 2026

  • Senzime says growing recurring revenues expected to strengthen business predictability

  • Company sees long-term market opportunity with estimated 80,000 EMG-based monitors in use over next decade


Result Drivers

  • RECURRING SENSOR SALES - Co said recurring sales of disposable sensors grew 43% and accounted for 83% of total Q3 sales, driving revenue growth

  • REGIONAL SALES GROWTH - Co reported net sales growth across all regions, with increases of 9% in the US, 20% in Europe, and 33% in the rest of the world

  • COST REDUCTIONS - Co said continued cost reductions contributed to improved cash flow and narrowed EBITDA loss


Company press release: ID:nMFN9tdcPd


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q3 Sales

Slight Beat*

SEK 30.10 mln

SEK 30 mln (1 Analyst)

Q3 Loss Per Share

SEK 0.07

Q3 Adjusted Gross Margin

74.00%

Q3 EBITDA

-SEK 8.03 mln

Q3 Operating Expenses

SEK 31.04 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.


Analyst Coverage

  • Wall Street's median 12-month price target for Senzime AB (publ) is SEK8.69, about 209.8% above its October 28 closing price of SEK2.81


Reuters Recommended Reads

  • Oct 28 - Bausch + Lomb beats Q3 adjusted EPS estimates; raises FY outlook

  • Oct 28 - Glaukos Q3 revenue jumps 58% on iDose TR, Epioxa launches, Corneal Health growth

  • Oct 26 - France's MEMSCAP Q3 revenue rises on medical and aerospace strength


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Recent news on Senzime AB (publ)

See all news